Physician's First Watch Archive

Medical news from NEJM Journal Watch

May 25, 2016

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

High sodium intake in patients with chronic kidney disease (CKD) is associated with increased risk for cardiovascular events, a JAMA study suggests.

Nearly …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Metabolic surgery, such as gastric bypass, is recommended to treat type 2 diabetes in obese patients, according to new international guidelines that came out of …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Over a quarter of all antidepressant prescriptions in Canada were for …

May 24, 2016

By John D. Cowden, MD, MPH

Dr. Cowden is associate editor of NEJM Journal Watch Pediatrics and Adolescent Medicine, from which this summary was adapted.

Gradually delaying infant's bedtime or parents' response to infant's crying improves sleep and is not associated with increased stress or …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Blood pressure readings that vary significantly over time are associated with faster cognitive decline among older adults, according to a …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

The American College of Obstetricians and Gynecologists offers an ethical framework for how to approach situations in which pregnant women decline recommended interventions. …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

For patients with stable chest pain, overall costs are generally similar between those who initially undergo anatomical testing and those who receive functional testing, …

May 23, 2016

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Valsartan/sacubitril and ivabradine are recommended for heart failure in updated guidelines from the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America.

Valsartan/sacubitril is an angiotensin receptor-neprilysin inhibitor (ARNI). By blocking that receptor, it inhibits …

Pages